Phase I Trial HIPEC With Nal-irinotecan

Conditions:   Peritoneal Cancer;   Pseudomyxoma Peritonei;   Mucinous Adenocarcinoma;   Mucinous Tumor;   Colorectal Cancer;   Gastric Cancer;   Primary Peritoneal Carcinoma;   Mesothelioma Intervention:   Drug: nanoliposomal irinotecan Sponsors:   Stony Brook University;   University of Kentucky;   University of San Diego Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials